user avatar
Declan Murphy
@declangmurphy
Urologist & Director of GU Oncology, Peter MacCallum Cancer Centre | Professor, University of Melbourne | Podcasting at GU Cast. Views my own. RT = endorsement
Melbourne, Australia
Joined March 2011
Posts
  • user avatar
    Prostate Cancer Along the Yellow Brick World. Looking forward to this talk at #eanm21 next weekend! Thanks @stefanofanti4 @officialEANM for the invite. Sneak peak
    00:00
  • user avatar
    Well there you go!! ๐Ÿ˜ฒ
    Congratulations to PROFESSOR @declangmurphy - just promoted to the position of Full Professor within the Sir Peter MacCallum Department of Oncology @unimelb ๐Ÿ‘๐ŸŽ‰ @PeterMacCC @gu_onc
  • user avatar
    What happens if you do a PSMA PET in โ€œM0/non-metastaticโ€ CRPC a lร  SPARTAN?? Answer - 98% have metastases! @DrMHofman @gu_onc @PeterMacCC #usanz19
  • user avatar
    Replying to @benchallacombe and @nishanturo
    Agree Ben. Here is my โ€œstanding asideโ€ email for a global meeting I declined recently. No excuses. Convenors should take a position if we are to make a difference #manel
  • user avatar
    Happening nowโ€ฆ Vip Patel using the Edge Medical robot on a patient in Harbin, China. But he is 1200km away in Beijing! Zero latency. Looks like a Da Vinci S HD #telesurgery #roboticsurgery @gu_onc
    00:00
  • user avatar
    Australian Government advisory committee issues positive recommendation for funding of PSMA PET/CT for primary staging and biochemical recurrence. Great day for Aussie prostate cancer patients. Hopefully @GregHuntMP will enact soon! @pros_tic @DrMHofman msac.gov.au/internet/msac/โ€ฆ
  • user avatar
    We are pleased to have our first patient on #LuTectomy trial - LuPSMA prior to robotic prostatectomy. Part of our #UpFront PSMA grant thanks to @MovemberAUS @CancerAustralia @pros_tic @PeterMacCC @EJWFoundation @Epworth clinicaltrials.gov/ct2/show/NCT04โ€ฆ
  • user avatar
    Sitting here at #ESMO23 watching randomized data on thousands of patients showing (yet again) that immunotherapy doesnโ€™t improve outcomes for prostate cancer patients. And causes lots of side-effects. Give up folks!
  • user avatar
    Congratulations to @lawrentschuk who has been appointed Head of Urology @TheRMH. Congrats Nathan!! Will continue ongoing roles @PeterMacCC @gu_onc @Epworth @EJWFoundation and strong links to @AustinUrology. Fantastic boost for collaboration, training & research @USANZUrology
  • user avatar
    Looking forward to #EAU21 next week. Although only virtual, it's still my favourite meeting of the year. Have loaded my "broadcasts", here's a trailer! @Uroweb #nomorepowerpoint #fcpx
    00:00
  • user avatar
    Epic evening in Paris. Two great teams well done Ireland #RWC2023 #IREvRSA
  • user avatar
    A better question - can some women replace some men on the panel? Jeez. These are all great experts (and friends), but I do hate a #manel #ilooklikeasurgeon #ilooklikeaurologist
    Can #FocalTherapy replace #Prostatectomy in localized prostate cancer? ๐Ÿ—“๏ธFeb/19/2021 โฐ12pm ET๐Ÿ‡บ๐Ÿ‡ธ; 9am PT๐Ÿ‡บ๐Ÿ‡ธ; 5pm๐Ÿ‡ฌ๐Ÿ‡ง ๐Ÿ“Link bit.ly/36R6db0 @ThomasPolascik @pcarroll @KlotzLaurence @EmbertonMark @FocalSociety @Endo_Society @NYUUrology @UCSFUrology @DukeUrology @USC_Urology
  • user avatar
    Impact factors are out! Well done to all the major urology journals @BJUIjournal @EUplatinum @pcan_journal @NatRevUrol @JUrology
  • user avatar
    95% of @APCCC_Lugano Panellists DO NOT recommend ARPI switch for mCRPC. Yet why do investigators (many of them Panellists) and FDA approve this as control arm for trials?? โ€œUnethicalโ€ says @AnthonyMJoshua from the floor, as did @VPrasadMDMPH on GU Cast @gu_onc #APCCC24